• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性ULBP通过下调NKG2D表达来抑制自然杀伤细胞活性。

Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.

作者信息

Song Hyunkeun, Kim JeongKi, Cosman David, Choi Inpyo

机构信息

Department of Anatomy, Inje University College of Medicine, Pusan 614-735, Republic of Korea.

出版信息

Cell Immunol. 2006 Jan;239(1):22-30. doi: 10.1016/j.cellimm.2006.03.002. Epub 2006 Apr 21.

DOI:10.1016/j.cellimm.2006.03.002
PMID:16630603
Abstract

NKG2D is an activating receptor that is expressed on most natural killer (NK) cells and CD8(+) T cells. MHC class I-related chain A(MICA) and UL16-binding protein (ULBP) 1, 2, and 3 are well-known ligands for NKG2D. Human gastric cancer cell lines, SNU216 and SNU638 cells which expressed UL16-binding protein (ULBP) were susceptible to NK cells in a NKG2D-dependent manner. However, SNU484 and SNU620 cells which had no ULBP on their surface were resistant to NK cells. ULBP 1, 2, and 3 are glycosylphosphatidylinositol (GPI)-anchored proteins which are sensitive to phosphatidylinositol-specific phospholipase C (PI-PLC). When SNU620 cells were treated with U73122, an inhibitor of PI-PLC, the surface expression of ULBP was elevated with increased NK susceptibility. Pre-incubating NK cells with culture supernatants of SNU620 or SNU638 cells, which contained soluble ULBP protein, reduced NK cell activity by decreasing surface expression of NKG2D in NK cells. Furthermore, recombinant ULBP-Fc induced the down-regulation of NKG2D expression in NK cells. Taken together, down-regulation of NKG2D by soluble ULBP provides a potential mechanism by which gastric cancer cells escape NKG2D-mediated attack by the immune cells.

摘要

NKG2D是一种激活受体,在大多数自然杀伤(NK)细胞和CD8(+) T细胞上表达。MHC I类相关链A(MICA)和UL16结合蛋白(ULBP)1、2和3是NKG2D的著名配体。表达UL16结合蛋白(ULBP)的人胃癌细胞系SNU216和SNU638细胞以NKG2D依赖的方式对NK细胞敏感。然而,表面没有ULBP的SNU484和SNU620细胞对NK细胞具有抗性。ULBP 1、2和3是糖基磷脂酰肌醇(GPI)锚定蛋白,对磷脂酰肌醇特异性磷脂酶C(PI-PLC)敏感。当用PI-PLC抑制剂U73122处理SNU620细胞时,ULBP的表面表达升高,NK敏感性增加。用含有可溶性ULBP蛋白的SNU620或SNU638细胞培养上清液预孵育NK细胞,通过降低NK细胞中NKG2D的表面表达来降低NK细胞活性。此外,重组ULBP-Fc诱导NK细胞中NKG2D表达的下调。综上所述,可溶性ULBP对NKG2D的下调提供了一种潜在机制,通过该机制胃癌细胞能够逃避免疫细胞介导的NKG2D攻击。

相似文献

1
Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.可溶性ULBP通过下调NKG2D表达来抑制自然杀伤细胞活性。
Cell Immunol. 2006 Jan;239(1):22-30. doi: 10.1016/j.cellimm.2006.03.002. Epub 2006 Apr 21.
2
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.不同组织类型肿瘤细胞系上主要组织相容性复合体I类相关链A和UL16结合蛋白的表达:肿瘤对NKG2D依赖性自然杀伤细胞细胞毒性的易感性分析
Cancer Res. 2002 Nov 1;62(21):6178-86.
3
Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.应激诱导蛋白ULBP和MICA的细胞表面组织,其通过NKG2D刺激人自然杀伤细胞和T细胞。
J Exp Med. 2004 Apr 5;199(7):1005-10. doi: 10.1084/jem.20032194. Epub 2004 Mar 29.
4
Proteolytic release of soluble UL16-binding protein 2 from tumor cells.肿瘤细胞中可溶性UL16结合蛋白2的蛋白水解释放。
Cancer Res. 2006 Mar 1;66(5):2520-6. doi: 10.1158/0008-5472.CAN-05-2520.
5
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.组蛋白去乙酰化酶抑制剂丙戊酸钠通过特异性诱导NKG2D配体介导自然杀伤细胞对肝癌细胞的杀伤作用。
Cancer Res. 2005 Jul 15;65(14):6321-9. doi: 10.1158/0008-5472.CAN-04-4252.
6
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.作为人类神经母细胞瘤免疫逃逸策略的NKG2D配体下调和/或释放
Neoplasia. 2004 Sep-Oct;6(5):558-68. doi: 10.1593/neo.04316.
7
Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.树突状细胞上自然杀伤细胞2D配体UL16结合蛋白-1(ULBP-1)的表达。
Eur J Immunol. 2006 Jan;36(1):65-72. doi: 10.1002/eji.200535115.
8
TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.转化生长因子-β和金属蛋白酶对恶性胶质瘤细胞表面NKG2D配体的表达有不同程度的抑制作用。
Brain. 2006 Sep;129(Pt 9):2416-25. doi: 10.1093/brain/awl205. Epub 2006 Aug 3.
9
Four novel ULBP splice variants are ligands for human NKG2D.四种新型ULBP剪接变体是人类NKG2D的配体。
Int Immunol. 2008 Aug;20(8):981-91. doi: 10.1093/intimm/dxn057. Epub 2008 Jun 10.
10
Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.NKG2D与高度相关的人类NKG2D配体ULBP2和RAET1G的差异性结合由α2结构域中的单个氨基酸决定。
Eur J Immunol. 2009 Jun;39(6):1642-51. doi: 10.1002/eji.200839074.

引用本文的文献

1
ULBP2 CAR-T cells enhance gastric cancer immunotherapy by inhibiting CAF activation.ULBP2嵌合抗原受体T细胞通过抑制癌症相关成纤维细胞(CAF)的激活来增强胃癌免疫治疗效果。
Cell Death Dis. 2025 Aug 8;16(1):597. doi: 10.1038/s41419-025-07905-5.
2
Ectopic ULBP2 Is Associated with Decreased NKG2D Expression in CD8 T Cells Under T Cell-Modulatory Conditions in a Murine Tumor Model.在小鼠肿瘤模型的T细胞调节条件下,异位ULBP2与CD8 T细胞中NKG2D表达降低有关。
Cells. 2025 Jun 13;14(12):893. doi: 10.3390/cells14120893.
3
N-methyladenosine RNA base modification regulates NKG2D-dependent and cytotoxic genes expression in natural killer cells.
N-甲基腺苷RNA碱基修饰调节自然杀伤细胞中NKG2D依赖性和细胞毒性基因的表达。
BMC Med Genomics. 2025 May 19;18(1):91. doi: 10.1186/s12920-025-02147-y.
4
ULBP2 Promotes Tumor Progression by Suppressing NKG2D-Mediated Anti-Tumor Immunity.ULBP2通过抑制NKG2D介导的抗肿瘤免疫促进肿瘤进展。
Int J Mol Sci. 2025 Mar 24;26(7):2950. doi: 10.3390/ijms26072950.
5
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation.23ME - 01473,一种Fc效应增强型抗ULBP6/2/5抗体,通过激活NKG2D和FcγRIIIa恢复自然杀伤细胞介导的抗肿瘤免疫。
Cancer Res Commun. 2025 Mar 1;5(3):476-495. doi: 10.1158/2767-9764.CRC-24-0478.
6
HCMV Variants Expressing ULBP2 Enhance the Function of Human NK Cells via its Receptor NKG2D.表达ULBP2的人巨细胞病毒变体通过其受体NKG2D增强人自然杀伤细胞的功能。
Eur J Immunol. 2025 Feb;55(2):e202451266. doi: 10.1002/eji.202451266.
7
Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies.采用种间交叉反应性 NKG2D 结合物的双特异性杀伤细胞接合器将人源和鼠源淋巴细胞重定向至 ErbB2/HER2 阳性恶性肿瘤。
Front Immunol. 2024 Aug 29;15:1457887. doi: 10.3389/fimmu.2024.1457887. eCollection 2024.
8
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome.可溶性 NKG2DLs 在乳腺癌患者中升高,并与疾病结局相关。
Int J Mol Sci. 2024 Apr 8;25(7):4126. doi: 10.3390/ijms25074126.
9
IDH mutation, glioma immunogenicity, and therapeutic challenge of primary mismatch repair deficient IDH-mutant astrocytoma PMMRDIA: a systematic review.异柠檬酸脱氢酶(IDH)突变、胶质瘤免疫原性以及原发性错配修复缺陷型IDH突变星形细胞瘤(PMMRDIA)的治疗挑战:一项系统综述
Mol Oncol. 2024 Dec;18(12):2822-2841. doi: 10.1002/1878-0261.13598. Epub 2024 Feb 9.
10
Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells.双特异性杀伤细胞衔接子靶向 EGFR 和 ErbB2(HER2)双重靶向促进 NKG2D-CAR 工程化 NK 细胞的有效清除胶质母细胞瘤细胞。
Cells. 2024 Jan 28;13(3):246. doi: 10.3390/cells13030246.